Related Experiment Video
Updated: Jan 15, 2026
Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Prevalence of Metabolic Syndrome in Iran: An Umbrella Review Across Diagnostic Criteria and Population Subgroups
Mojtaba Sepandi1, Maryam Taghdir1, Yousef Alimohamadi1
1Health Research Center, Life Style Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Background:
Metabolic Syndrome (MetS) is a significant public health concern globally, driven by factors like obesity and sedentary lifestyles. In Iran, numerous meta-analyses have estimated its prevalence, but results vary. This umbrella review aims to synthesize these findings to provide a definitive summary of MetS prevalence across both general and high-risk populations in Iran.
Methods:
We systematically searched international (PubMed/Medline, Scopus, Web of Science) and Persian databases (SID, Magiran) for meta-analyses published between January 2014 and August 2025 reporting pooled MetS prevalence in Iranian populations. Data extraction covered overall prevalence, subgroup analyses (gender, diagnostic criteria, population risk strata), and study characteristics. Methodological quality was assessed using AMSTAR 2, and evidence quality was evaluated using GRADE framework. Meta-analysis of pooled estimates was performed using random-effects models.
Results:
Nineteen meta-analyses comprising 119 prevalence estimates and 1,954,049 participants were included. The overall pooled prevalence of MetS in Iran was 30.4% (95% CI: 28.44-32.33). Prevalence was higher in females (33.05%) than in males (27.57%). The prevalence varied by diagnostic criteria, with the Joint Interim Statement (JIS) criteria yielding the highest estimate (36.47%), followed by the International Diabetes Federation (IDF) criteria (32.03%), and the NCEP-ATP III criteria (26.86%). High heterogeneity (I2 > 99%) was observed. The methodological quality of included studies was predominantly moderate, and the GRADE evidence quality for most outcomes was moderate.
Conclusion:
Approximately one in three Iranian adults is affected by MetS, with disproportionately higher burden among women and specific high-risk populations. The choice of diagnostic criteria significantly influences prevalence estimates, and considerable heterogeneity across studies highlights the context-dependent nature of these findings. These results underscore the urgent need for targeted public health interventions and systematic screening strategies tailored to different population risk profiles.
Registration Information:
The study protocol was registered in the Prospero with ID, CRD420251182425.
More Related Videos
09:44Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
Published on: March 5, 2022
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
Related Concept Videos
01:15Diabetes: Symptoms, Diagnosis, and Complications
01:24Obesity
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
01:08Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
01:24Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...